- Home
- RILY vs CLYM Comparison
RILY vs CLYM Comparison
Compare RILY & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RILY
- CLYM
- Stock Information
- Founded
- RILY 1973
- CLYM 2018
- Country
- RILY United States
- CLYM United States
- Employees
- RILY N/A
- CLYM N/A
- Industry
- RILY Investment Managers
- CLYM
- Sector
- RILY Finance
- CLYM
- Exchange
- RILY Nasdaq
- CLYM NYSE
- Market Cap
- RILY 91.8M
- CLYM 86.5M
- IPO Year
- RILY 2007
- CLYM 2021
- Fundamental
- Price
- RILY $2.94
- CLYM $1.22
- Analyst Decision
- RILY
- CLYM Buy
- Analyst Count
- RILY 0
- CLYM 1
- Target Price
- RILY N/A
- CLYM $10.00
- AVG Volume (30 Days)
- RILY 727.6K
- CLYM 204.9K
- Earning Date
- RILY 08-14-2025
- CLYM 08-13-2025
- Dividend Yield
- RILY N/A
- CLYM N/A
- EPS Growth
- RILY N/A
- CLYM N/A
- EPS
- RILY N/A
- CLYM N/A
- Revenue
- RILY $854,383,000.00
- CLYM N/A
- Revenue This Year
- RILY N/A
- CLYM N/A
- Revenue Next Year
- RILY N/A
- CLYM N/A
- P/E Ratio
- RILY N/A
- CLYM N/A
- Revenue Growth
- RILY N/A
- CLYM N/A
- 52 Week Low
- RILY $2.67
- CLYM $1.05
- 52 Week High
- RILY $21.18
- CLYM $9.21
- Technical
- Relative Strength Index (RSI)
- RILY 42.38
- CLYM N/A
- Support Level
- RILY $2.79
- CLYM N/A
- Resistance Level
- RILY $3.34
- CLYM N/A
- Average True Range (ATR)
- RILY 0.17
- CLYM 0.00
- MACD
- RILY -0.01
- CLYM 0.00
- Stochastic Oscillator
- RILY 22.73
- CLYM 0.00
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.